Related Experiment Videos
Safety and immunogenicity of combined rabies and typhoid fever immunization
C Fritzell1, P E Rollin, M Touir
1Centre Antirabique, Hôpital de l'Institut Pasteur, Paris, France.
Vaccine
|January 1, 1992
Abstract:
The prevalence of rabies and typhoid fever in many developing countries poses a serious health hazard to travellers. The development of a combined immunization schedule would be advantageous. A study was performed on 104 adult volunteers using purified Vero cell rabies vaccine and Typhim Vi, a purified capsular polysaccharide, either separately or in combination. No significant difference was observed in immunogenicity or tolerance between the two groups. A 3-year follow-up study is planned.